Report Detail
Global Phenylketonuria (PKU) Market Insights, Forecast to 2025
- RnM2468741 |
- 25 March, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Phenylketonuria (PKU) refers to a genetic disorder and the disease is inherited from one’s parents. The patient suffers from a metabolic defect, in which the body stops being able to break down phenylalanine amino acid that is compromised of protein. Phenylalanine starts getting stored in the blood stream and it damages the brain in consequence.
PKU is caused due a defect in the gene which helps to produce phenylalanine hydroxylase. Absence of phenylalanine hydroxylase leads to a buildup of phenylalanine in the body. Timely diagnosis and treatment helps in terminating the symptoms of PKU and avoid brain damage.
The classification of Phenylketonuria (PKU) includes medications, supplements and others, and the revenue proportion of supplements in 2016 is about 34.48% and the revenue proportion of medications is about 42.47%.
Phenylketonuria (PKU) is widely used in household, hospital and other field. The most proportion of Phenylketonuria (PKU) is in household, and the sales proportion in 2016 is about 61.54%.
North America is the largest consumption place, with a consumption market share nearly 57.18% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 29.28%.
The global Phenylketonuria (PKU) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Phenylketonuria (PKU) market based on company, product type, end user and key regions.
This report studies the global market size of Phenylketonuria (PKU) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Phenylketonuria (PKU) in these regions.
This research report categorizes the global Phenylketonuria (PKU) market by top players/brands, region, type and end user. This report also studies the global Phenylketonuria (PKU) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Biomarin
Vitaflo
Mead Johnson
Nutricia
Abbott
Prominmetabolics
Cambrooke
Juvela
Firstplay Dietary
Market size by Product
Medications
Supplements
Market size by End User
Household
Hospital
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Phenylketonuria (PKU) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Phenylketonuria (PKU) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Phenylketonuria (PKU) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Phenylketonuria (PKU) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Phenylketonuria (PKU) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Phenylketonuria (PKU) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Phenylketonuria (PKU) Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Phenylketonuria (PKU) Market Size Growth Rate by Product
- 1.4.2 Medications
- 1.4.3 Supplements
- 1.5 Market by End User
- 1.5.1 Global Phenylketonuria (PKU) Market Size Growth Rate by End User
- 1.5.2 Household
- 1.5.3 Hospital
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Phenylketonuria (PKU) Market Size
- 2.1.1 Global Phenylketonuria (PKU) Revenue 2014-2025
- 2.1.2 Global Phenylketonuria (PKU) Sales 2014-2025
- 2.2 Phenylketonuria (PKU) Growth Rate by Regions
- 2.2.1 Global Phenylketonuria (PKU) Sales by Regions
- 2.2.2 Global Phenylketonuria (PKU) Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Phenylketonuria (PKU) Sales by Manufacturers
- 3.1.1 Phenylketonuria (PKU) Sales by Manufacturers
- 3.1.2 Phenylketonuria (PKU) Sales Market Share by Manufacturers
- 3.1.3 Global Phenylketonuria (PKU) Market Concentration Ratio (CR5 and HHI)
- 3.2 Phenylketonuria (PKU) Revenue by Manufacturers
- 3.2.1 Phenylketonuria (PKU) Revenue by Manufacturers (2014-2019)
- 3.2.2 Phenylketonuria (PKU) Revenue Share by Manufacturers (2014-2019)
- 3.3 Phenylketonuria (PKU) Price by Manufacturers
- 3.4 Phenylketonuria (PKU) Manufacturing Base Distribution, Product Types
- 3.4.1 Phenylketonuria (PKU) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Phenylketonuria (PKU) Product Type
- 3.4.3 Date of International Manufacturers Enter into Phenylketonuria (PKU) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Phenylketonuria (PKU) Sales by Product
- 4.2 Global Phenylketonuria (PKU) Revenue by Product
- 4.3 Phenylketonuria (PKU) Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Phenylketonuria (PKU) Breakdown Data by End User
6 North America
- 6.1 North America Phenylketonuria (PKU) by Countries
- 6.1.1 North America Phenylketonuria (PKU) Sales by Countries
- 6.1.2 North America Phenylketonuria (PKU) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Phenylketonuria (PKU) by Product
- 6.3 North America Phenylketonuria (PKU) by End User
7 Europe
- 7.1 Europe Phenylketonuria (PKU) by Countries
- 7.1.1 Europe Phenylketonuria (PKU) Sales by Countries
- 7.1.2 Europe Phenylketonuria (PKU) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Phenylketonuria (PKU) by Product
- 7.3 Europe Phenylketonuria (PKU) by End User
8 Asia Pacific
- 8.1 Asia Pacific Phenylketonuria (PKU) by Countries
- 8.1.1 Asia Pacific Phenylketonuria (PKU) Sales by Countries
- 8.1.2 Asia Pacific Phenylketonuria (PKU) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Phenylketonuria (PKU) by Product
- 8.3 Asia Pacific Phenylketonuria (PKU) by End User
9 Central & South America
- 9.1 Central & South America Phenylketonuria (PKU) by Countries
- 9.1.1 Central & South America Phenylketonuria (PKU) Sales by Countries
- 9.1.2 Central & South America Phenylketonuria (PKU) Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Phenylketonuria (PKU) by Product
- 9.3 Central & South America Phenylketonuria (PKU) by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Phenylketonuria (PKU) by Countries
- 10.1.1 Middle East and Africa Phenylketonuria (PKU) Sales by Countries
- 10.1.2 Middle East and Africa Phenylketonuria (PKU) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Phenylketonuria (PKU) by Product
- 10.3 Middle East and Africa Phenylketonuria (PKU) by End User
11 Company Profiles
- 11.1 Biomarin
- 11.1.1 Biomarin Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Biomarin Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Biomarin Phenylketonuria (PKU) Products Offered
- 11.1.5 Biomarin Recent Development
- 11.2 Vitaflo
- 11.2.1 Vitaflo Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Vitaflo Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Vitaflo Phenylketonuria (PKU) Products Offered
- 11.2.5 Vitaflo Recent Development
- 11.3 Mead Johnson
- 11.3.1 Mead Johnson Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Mead Johnson Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Mead Johnson Phenylketonuria (PKU) Products Offered
- 11.3.5 Mead Johnson Recent Development
- 11.4 Nutricia
- 11.4.1 Nutricia Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Nutricia Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Nutricia Phenylketonuria (PKU) Products Offered
- 11.4.5 Nutricia Recent Development
- 11.5 Abbott
- 11.5.1 Abbott Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Abbott Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Abbott Phenylketonuria (PKU) Products Offered
- 11.5.5 Abbott Recent Development
- 11.6 Prominmetabolics
- 11.6.1 Prominmetabolics Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Prominmetabolics Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Prominmetabolics Phenylketonuria (PKU) Products Offered
- 11.6.5 Prominmetabolics Recent Development
- 11.7 Cambrooke
- 11.7.1 Cambrooke Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Cambrooke Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Cambrooke Phenylketonuria (PKU) Products Offered
- 11.7.5 Cambrooke Recent Development
- 11.8 Juvela
- 11.8.1 Juvela Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Juvela Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Juvela Phenylketonuria (PKU) Products Offered
- 11.8.5 Juvela Recent Development
- 11.9 Firstplay Dietary
- 11.9.1 Firstplay Dietary Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Firstplay Dietary Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Firstplay Dietary Phenylketonuria (PKU) Products Offered
- 11.9.5 Firstplay Dietary Recent Development
12 Future Forecast
- 12.1 Phenylketonuria (PKU) Market Forecast by Regions
- 12.1.1 Global Phenylketonuria (PKU) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Phenylketonuria (PKU) Revenue Forecast by Regions 2019-2025
- 12.2 Phenylketonuria (PKU) Market Forecast by Product
- 12.2.1 Global Phenylketonuria (PKU) Sales Forecast by Product 2019-2025
- 12.2.2 Global Phenylketonuria (PKU) Revenue Forecast by Product 2019-2025
- 12.3 Phenylketonuria (PKU) Market Forecast by End User
- 12.4 North America Phenylketonuria (PKU) Forecast
- 12.5 Europe Phenylketonuria (PKU) Forecast
- 12.6 Asia Pacific Phenylketonuria (PKU) Forecast
- 12.7 Central & South America Phenylketonuria (PKU) Forecast
- 12.8 Middle East and Africa Phenylketonuria (PKU) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Phenylketonuria (PKU) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Phenylketonuria (PKU) . Industry analysis & Market Report on Phenylketonuria (PKU) is a syndicated market report, published as Global Phenylketonuria (PKU) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Phenylketonuria (PKU) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
